当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第5期
编号:13425661
甲型H1N1流感预后的预判因子研究进展(5)
http://www.100md.com 2019年2月5日 《医学信息》 2019年第5期
     [23]Tandel K,Sharma S,Dash PK,et al.Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015[J].J Med Virol,2018,90(5):836-843.

    [24]Thorlund K,Awad T,Boivin G,et al.Systematic review of influenza resistance to the neuraminidase inhibitors[J].BMC Infect Dis,2011(11):134.

    [25]Abed Y,Tu V,Carbonneau J,et al.Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation,in vitro and in animal models[J].Antiviral Res,2018,159(9):26-34.

    [26]Jarhult JD.Oseltamivir (Tamiflu○R) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans--a review[J].Infect Ecol Epidemiol,2012,2(10):3402.

    [27]孫甲君,李琛,吴大玮,等.成人甲型H1N1流感伴呼吸衰竭18例分析[J].中华危重病急救医学,2010,22(3):156-160.

    [28]Zangrillo A,Biondi-Zoccai G,Landoni G,et al.Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO[J].Crit Care,2013,17(1):R30.

    [29]Sukhal S,Sethi J,Ganesh M,et al.Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis[J].Ann Card Anaesth,2017,20(1):14-21.

    [30]Pappalardo F,Pieri M,Greco T,et al.Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score[J].Intensive Care Med,2013,39(2):275-281.

    收稿日期:2018-12-18;修回日期:2018-12-27

    编辑/杨倩, http://www.100md.com(袁金壑)
上一页1 2 3 4 5